SCHEMBL1484450

SCHEMBL1484450

COC1CNCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26499779 1.00
Hydrochloric Acid SCHEMBL27797668 0.98
SCHEMBL11414328 0.80 HTR1A (0.33)
SCHEMBL5627360 0.76
SCHEMBL2124905 0.76
SCHEMBL22413765 0.76 SLC6A2 (0.34)
SCHEMBL1620793 0.76
SCHEMBL2127211 0.76
SCHEMBL28162738 0.75
SCHEMBL28162737 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 354 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114317678-B Biological paper chip, high-throughput multi-detection microplate device, preparation method and kit for vaginal inflammation multi-detection 港龙生物技术(深圳)有限公司 2023-11-10 CN claimed
CN-107743502-A Solidification composition filling 爱客多有限公司 2018-02-27 CN claimed
US-20060116435-A1 High strength polyurethane foam COIM USA, INC. 2006-06-01 US claimed
EP-1337511-A1 BIS-HETEROCYCLIC COMPOUNDS WITH ANTITUMOUR AND CHEMOSENSITISING ACTIVITY Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) 2003-08-27 EP claimed
WO-2002036561-A1 BIS-HETEROCYCLIC COMPOUNDS WITH ANTITUMOUR AND CHEMOSENSITISING ACTIVITY SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2002-05-10 WO claimed
US-12202826-B2 N-pyridinyl acetamide derivatives as inhibitors of the Wnt signaling pathway REDX PHARMA PLC (GB) 2025-01-21 US disclosed
CN-118414337-A Pyrazolopyrimidine derivative and anticancer pharmaceutical composition containing same as active ingredient 韩国化学研究院 2024-07-30 CN disclosed
US-20240218055-A1 LASSA VIRUS-SPECIFIC NANOBODIES AND METHODS OF THEIR USE THE U.S.A., AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2024-07-04 US disclosed
US-20240199746-A1 ANTI-AXL ANTIBODIES, ANTIBODY FRAGMENTS AND THEIR IMMUNOCONJUGATES AND USES THEREOF BIOATLA, INC. (US) 2024-06-20 US disclosed
EP-3350224-B1 MONOCLONAL ANTIBODIES SPECIFIC FOR FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4) AND METHODS OF THEIR USE US HEALTH (US) 2024-06-19 EP disclosed
US-12012463-B2 High affinity monoclonal antibodies targeting glypican-2 and uses thereof THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2024-06-18 US disclosed
US-12012455-B2 Human monoclonal antibodies specific for FLT3 and uses thereof THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2024-06-18 US disclosed
US-4082773-A TRICYCLIC TETRAHYDRO NAPHTHALENEOLS AND RELATED COMPOUNDS E. R. SQUIBB & SONS, INC. (US) 1978-04-04 US disclosed
US-4053596-A HYPOTENSIVE AGENTS E. R. SQUIBB & SONS, INC. (US) 1977-10-11 US disclosed
US-4044040-A HYPERTENSIVE AGENTS E. R. SQUIBB & SONS, INC. (US) 1977-08-23 US disclosed
US-3984419-A HYPOTENSIVES E. R. SQUIBB & SONS, INC. (US) 1976-10-05 US disclosed
US-3982021-A Compositions for the treatment of coronary diseases containing tetrahydronaphthyloxy-aminopropanols E. R. SQUIBB & SONS, INC. (US) 1976-09-21 US disclosed
US-3951950-A ANTIVIRAL, CARDIOVASCULAR, ANTIINFLAMMATORY E. R. SQUIBB & SONS, INC. (US) 1976-04-20 US disclosed
US-3943149-A HYPOCHOLESTEREMIC, ANTIINFLAMMATORY E. R. SQUIBB & SONS, INC. (US) 1976-03-09 US disclosed
US-3935267-A CARDIOVASCULAR DISORDERS E. R. SQUIBB & SONS, INC. (US) 1976-01-27 US disclosed